Letter/Comment

The latest advocacy letters and comments from the American Hospital Association.

AHA letter to President Biden urging the Administration to take action to address IV solution supply shortage as a result of hurricane Helene.
AHA letter to HHS regarding the Department of Health and Human Services 'role in coordinating with the Drug Enforcement Administration to support the safe prescribing of controlled substances via telehealth.
AHA comments to the Drug Enforcement Administration regarding their efforts to support the safe prescribing of controlled substances via telehealth. Indeed, during the COVID-19 public health emergency
The AHA provides comments to the Assistant Secretary for Technology Policy (ASTP) on the Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public Health Interoperability (HTI-2) proposed rule.
The AHA applauds the U.S. Department of Health and Human Services Office of Inspector General (HHS OIG) for your recently announced review of Medicare Advantage Organizations' Use of Prior Authorization for Post-Acute Care.
AHA urges CMS to consider whether adjustments are necessary in its approach to annual market basket updates to ensure that beneficiaries continue to have access to high-quality outpatient care. We also urge CMS to eliminate the productivity cut for CY 2025, as detailed below.
The AHA urges CMS to work with Congress to provide a Physician Fee Schedule payment increase for 2025 and to develop a long-term plan for sustainable physician payment.
The American Hospital Association requests additional funding for the Federal Emergency Management Agency’s Disaster Relief Fund which provides support for authorized federal disaster activities.
AHA letter regarding the Health Resources and Services Administration’s response to Johnson & Johnson’s (J&J) most recent attempt to undermine the 340B Drug Pricing Program.
The AHA provides comments to CMS on the calendar year 2025 Home Health prospective payment system proposed rule.